The Serum Institute of India became the first company to re-license a vaccine for use outside of the cold chain - the cold chain is a method of constant refrigeration that is required for most vaccines to keep their potency but which is completely unrealistic for many rural areas in developing countries. The Meningitis A vaccine can now be kept outside of refrigeration at temperatures up to 104 F (40C) for up to 4 days. As a result, many more children will have access to this life-saving vaccine. So what incentives do pharmaceutical companies need to produce more better adapted vaccines for developing countries?
How Can We Vaccinate More Children?
Jan 10, 2014
Get the latest updates on our work